News - Pharmaphorum

Latest News

in News
FCB Health opens Frankfurt office as part of European expansion
October 4, 2018 Share
X
FCB Health opens Frankfurt office as part of European expansion
https://pharmaphorum.com/news/fcb-health-jamie-maccarthy-morrogh-david-prater/
in News
ICR acquires Continuum Health to expand its healthcare practice
October 2, 2018 Share
X
ICR acquires Continuum Health to expand its healthcare practice
https://pharmaphorum.com/news/icr-healthcare-continuum-health/

earthware appoints Roche’s Karl Wilson as client excellence director

UK-based digital consultancy earthware has appointed Karl Wilson as client excellence director in a role that will also

earthware appoints Roche’s Karl Wilson as client excellence director

https://pharmaphorum.com/news/earthware-roche-karl-wilson/

Bedrock, DDB and Insypher lead at PM Society Digital Awards 2018

Bedrock, DDB Remedy and Insypher each scored two Golds at last night’s PM Society Digital Awards 2018 in

Bedrock, DDB and Insypher lead at PM Society Digital Awards 2018

https://pharmaphorum.com/news/pm-society-digital-awards-2018/

FCB Health evolves Hudson Global into Area 23 On Hudson

FCB Health has evolved its Hudson Global agency into a new offering that will be under the leadership

FCB Health evolves Hudson Global into Area 23 On Hudson

https://pharmaphorum.com/news/fcb-health-area-23-hudson/

See all

More news

GLOBALHealthPR adds Spurwing Communications to its network

GLOBALHealthPR has boosted its Asia-Pacific reach with the addition of Spurwing Communications to its independent med comms network.

GLOBALHealthPR adds Spurwing Communications to its network

https://pharmaphorum.com/news/globalhealthpr-singapore-spurwing-communications/

Ketchum hires Con Franklin as London healthcare MD

Con Franklin has joined communications consultancy Ketchum as its managing director of healthcare in London. He joins the

Ketchum hires Con Franklin as London healthcare MD

https://pharmaphorum.com/news/ketchum-con-franklin-healthcare-md/

Cello Health acquires Firstlight PR’s health team

Cello Health has boosted its comms offering with the acquisition of Firstlight Public Relations’ ten-strong healthcare business. The

Cello Health acquires Firstlight PR’s health team

https://pharmaphorum.com/news/cello-health-acquires-firstlight-pr-health/

AZ COPD drug fails to match GSK rival after disappointing launch

AstraZeneca has said it is analysing “inconsistent” results after a late-stage trial of its Bevespi Aerosphere inhaler in

AZ COPD drug fails to match GSK rival after disappointing launch

https://pharmaphorum.com/news/az-copd-drug-fails-match-gsk-rival/

FDA refuses to approve Insys opioid painkiller

The US regulators have rejected Insys Therapeutics’ opioid-based painkiller because of concerns about its safety. The FDA knock-back

FDA refuses to approve Insys opioid painkiller

https://pharmaphorum.com/news/fda-insys-therapeutics-opioid-painkiller/

Bayer hits back at Netflix medical device documentary

Bayer has issued a robust defence of Essure after the birth control implant was featured in The Bleeding

Bayer hits back at Netflix medical device documentary

https://pharmaphorum.com/news/bayer-netflix-essure-safety/

Amazon interested in Indian pharmacy chain

Seattle based e-commerce giant Amazon is thinking about a serious investment in MedPlus, the second largest pharmacy chain

Amazon interested in Indian pharmacy chain

https://pharmaphorum.com/news/amazon-interested-in-indian-pharmacy-chain/

FDA approves Janssen’s HIV combination Symtuza

Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient

FDA approves Janssen’s HIV combination Symtuza

https://pharmaphorum.com/news/fda-janssen-hiv-symtuza/

Amgen and UCB re-file Evenity for US approval

Amgen and UCB have resubmitted their application for US approval of Evenity as an osteoporosis treatment, hoping that

Amgen and UCB re-file Evenity for US approval

https://pharmaphorum.com/news/amgen-ucb-evenity-fda-filing/

Pfizer splits into three after failing to sell consumer unit

Pfizer has decided to split into three after it failed to sell its consumer healthcare business a few

Pfizer splits into three after failing to sell consumer unit

https://pharmaphorum.com/news/pfizer-splits-into-three-after-failing-to-sell-consumer-unit/

J&J offered $2.7 billion for sterilisation business by Fortive

Johnson & Johnson (J&J) has announced that Fortive Corp has made an offer of about $2.7 billion in cash for its Advanced Sterilisation Products (ASP) business.

J&J offered $2.7 billion for sterilisation business by Fortive

https://pharmaphorum.com/news/jnj-sterilisation-business-fortive/

EMA warns Brexit move will cause higher-than-expected staff losses

Europe’s medicines regulator is expecting higher-than-anticipated staff departures as a result of its Brexit-induced move from London to

EMA warns Brexit move will cause higher-than-expected staff losses

https://pharmaphorum.com/news/ema-brexit-staff-losses-amsterdam/

Roche haemophilia data piles pressure on Shire

Hemlibra threatens to take market share from Advate

Roche haemophilia data piles pressure on Shire

https://pharmaphorum.com/news/roche-haemophilia-data-piles-pressure-on-shire/

Novartis/Amgen’s migraine drug hits market at lower than expected price

The FDA has approved the first in a new class of migraine drugs, Novartis and Amgen’s Aimovig, and

Novartis/Amgen’s migraine drug hits market at lower than expected price

https://pharmaphorum.com/news/novartis-amgens-aimovig-hits-market-at-lower-than-expected-price/

Takeda to cut IT, marketing and sales jobs after Shire merger

Takeda aiming for $1.4bn savings per year

Takeda to cut IT, marketing and sales jobs after Shire merger

https://pharmaphorum.com/news/takeda-to-cut-it-marketing-and-sales-jobs-after-shire-merger/

Search

Advanced Search

Trending

Latest News

More news